The pandemic is creating massive shifts in the market and pharmaceutical companies are taking big strides to position themselves as Consumer Healthcare, Animal Health or Rare Disease leader for example. Mergers and acquisitions are on the rise to stay competitive and combat the increased pricing pressures.

The global pandemic made it even harder to be successful in pharma pricing. The whole situation will make a big impact on the budget and supply chain and product availability. The government response will always try to reduce Healthcare expenses and as consequence and pharmaceutical price controls will increase. This is when the value will be the new Pharma currency and we´ll see new innovative pricing models in the market.

At times like this, when there are so many unknowns, it can seem like the perfect storm – but we think this situation will act as an innovative pricing incubator and Vistex is here to help.

In this webinar, we´ll analyze not only the current situation but also we’ll go through the new emerging pricing models that are arising. Which ones are Hype and which one’s Hope?

Watch this webinar now on-demand and learn more about:

  • The current situation in the Pharma industry
  • Emerging trends: Which ones can help us to move ahead and which ones will leave us behind?
  • How to do a full-insight trend analysis
  • How Vistex can support you

Presenter:

Alejandra Garitonandia - Business Development Manager for Life Sciences at Vistex EMEA

Alejandra Garitonandia
Business Development Manager for Life Sciences at Vistex EMEA

Alejandra Garitonandía is the Business Development Manager for Life Sciences at Vistex EMEA. She is specialized in revenue management for Pharma and has a background in medical and business educational studies. During her international career, she holds different positions in business and IT. Her specialization is where business processes meet the IT systems and how to support efficient end-to-end revenue management. 

See how it all adds up

Watch the On-Demand Webinar Now